Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 1/20 | 0.69 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.69 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.69 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | MAOA | P21397 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.52 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dibemethine SCHEMBL10542007 | 0.85 | ALDH1A1 (0.70) | CARM1PRMT6PRMT8AOC3ALDH1A1 | |
| Dibemethine SCHEMBL276863 | 0.85 | ALDH1A1 (0.70) | CARM1PRMT6PRMT8AOC3ALDH1A1 | |
| Dibemethine SCHEMBL2139708 | 0.82 | ALDH1A1 (0.67) | CARM1PRMT6PRMT8AOC3ALDH1A1 | |
| SCHEMBL7039241 | 0.82 | CARM1 (0.64) | CARM1PRMT6PRMT8AOC3ALDH1A1 | |
| SCHEMBL1395704 | 0.82 | CARM1 (1.00) | CARM1PRMT6PRMT8AOC3ALDH1A1 | |
| Hydrochloric Acid SCHEMBL17372655 | 0.80 | CARM1 (0.96) | CARM1PRMT6PRMT8AOC3ALDH1A1 | |
| SCHEMBL7055109 | 0.80 | CARM1 (0.75) | CARM1PRMT6PRMT8AOC3ALDH1A1 | |
| SCHEMBL11278307 | 0.80 | ALDH1A1 (0.64) | CARM1PRMT6PRMT8AOC3ALDH1A1 | |
| SCHEMBL2108172 | 0.79 | CARM1 (0.78) | CARM1PRMT6PRMT8AOC3ALDH1A1 | |
| SCHEMBL355111 | 0.78 | TSHR (0.61) | CARM1PRMT6PRMT8AOC3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10221276-B2 | Self-healing epoxy resin composition | ADITYA BIRLA CHEMICALS (THAILAND) LTD. (TH) | 2019-03-05 | — | — | US | disclosed |
| EP-3309157-A1 | ANTIVIRAL COMPOUNDS | Gilead Pharmasset LLC (US) | 2018-04-18 | — | — | EP | disclosed |
| CN-105682936-B | A kind of selfreparing composition epoxy resin | 阿迪塔亚博拉化学品（泰国）有限公司 | 2017-09-15 | — | — | CN | disclosed |
| US-20160229950-A1 | SELF-HEALING EPOXY RESIN COMPOSITION | ADITYA BIRLA CHEMICALS (THAILAND) LTD. (TH) | 2016-08-11 | — | — | US | disclosed |
| CN-105682936-A | A self-healing epoxy resin composition | 阿迪塔亚博拉化学品（泰国）有限公司 | 2016-06-15 | — | — | CN | disclosed |
| US-8871756-B2 | Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease | HOFFMANN-LA ROCHE INC. (US) | 2014-10-28 | — | — | US | disclosed |
| US-20130196974-A1 | COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE | HOFFMANN-LA ROCHE INC. | 2013-08-01 | — | — | US | disclosed |
| CN-1253603-A | Carbamate modified low-molecular polymer compound and use thereof for after-treatment of dyed or printed cellulose textile material | TEXTILCOLOR AG (CH) | 2000-05-17 | — | — | CN | disclosed |
| EP-0963478-A1 | CARBAMATE MODIFIED LOW-MOLECULAR POLYMER COMPOUND AND THE USE THEREOF FOR AFTER-TREATMENT OF DYED OR PRINTED CELLULOSE TEXTILE MATERIAL | TEXTIL COLOR AG (CH) | 1999-12-15 | — | — | EP | disclosed |
| WO-1998038378-A1 | CARBAMATE MODIFIED LOW-MOLECULAR POLYMER COMPOUND AND THE USE THEREOF FOR AFTER-TREATMENT OF DYED OR PRINTED CELLULOSE TEXTILE MATERIAL | TEXTILCOLOR AG (CH) | 1998-09-03 | — | — | WO | disclosed |
| EP-0492501-B1 | Surface-active triazine compounds, process for their preparation and their use | HOECHST AG (DE) | 1996-11-20 | — | — | EP | disclosed |
| US-5240499-A | Polymeric pigments | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-08-31 | — | — | US | disclosed |
| EP-0492501-A1 | Surface-active triazine compounds, process for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-07-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130196974-A1 | COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE | CFTR, H1-10, RECQL | CARM1 1912/4885PRMT6 1197/4885PRMT8 1288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.